Description
This book covers various aspects of antibody mediated drug delivery systems – theoretical aspects, processing, viral and non-viral vectors, and fields where these systems find and /or are being evaluated for applications as therapeutics and diagnostic treatment. Chapters discuss actual applications of techniques used for formulation and characterization. Applications areas include cancer, pulmonary, ocular diseases; brain drug delivery; and vaccine delivery. The contributing authors represent over 10 different countries, covering recent developments happening around the globe.
Chapter
CHAPTER 2 IMMUNOLIPOSOMES FOR CARDIOVASCULAR TARGETING
pp.:
37 – 59
CHAPTER 3 ANTIBODY-MEDIATED DRUG DELIVERY SYSTEMS FOR BREAST CANCER THERAPEUTICS
pp.:
59 – 81
CHAPTER 4 DEVELOPMENT OF IMMUNONCONJUGATES FOR IN VIVO DELIVERY: CANCER DIAGNOSIS, IMAGING, AND THERAPY
pp.:
81 – 107
CHAPTER 5 MATHEMATICAL MODELS OF ANTI-TNF THERAPIES AND THEIR CORRELATION WITH TUBERCULOSIS
pp.:
107 – 129
CHAPTER 6 TARGETED NANOPARTICLES IN RADIOTHERAPY
pp.:
129 – 153
CHAPTER 7 ELECTRICALLY-ENHANCED DELIVERY OF DRUGS AND CONJUGATES FOR CANCER TREATMENT
pp.:
153 – 169
CHAPTER 8 CHARACTERIZATION OF MONOCLONAL ANTIBODY VARIANTS AND GLYCOSYLATION
pp.:
169 – 193
CHAPTER 9 ANTIBODY-MEDIATED DRUG DELIVERY SYSTEM FOR LYMPHATIC TARGETING TREATMENT
pp.:
193 – 215
CHAPTER 10 METHODS FOR NANOPARTICLE CONJUGATION TO MONOCLONAL ANTIBODIES
pp.:
215 – 233
CHAPTER 11 SINGLE-USE SYSTEMS IN ANIMAL CELL–BASED BIOPRODUCTION
pp.:
233 – 253
CHAPTER 12 IMMUNOLIPOSOMES FOR SPECIFIC DRUG DELIVERY
pp.:
253 – 291
CHAPTER 13 GENE THERAPY TARGETING KIDNEY DISEASES: ROUTES AND VEHICLES
pp.:
291 – 303
CHAPTER 14 DETECTION OF ANTIBODIES TO POLY(ETHYLENE GLYCOL) POLYMERS USING DOUBLE-ANTIGEN-BRIDGING IMMUNOGENICITY ELISA
pp.:
303 – 315
CHAPTER 15 ANTIBODIES IN NANOMEDICINE AND MICROIMAGING METHODS
pp.:
315 – 375
CHAPTER 16 METHODS FOR POLYMERIC NANOPARTICLE CONJUGATION TO MONOCLONAL ANTIBODIES
pp.:
375 – 389
CHAPTER 17 PLANT-DERIVED ANTIBODIES FOR ACADEMIC, INDUSTRIAL, AND THERAPEUTIC APPLICATIONS
pp.:
389 – 407
CHAPTER 18 MONOCLONAL ANTIBODIES AS BIOPHARMACEUTICALS
pp.:
407 – 415
CHAPTER 19 PULMONARY TARGETING OF NANOPARTICLES AND MONOCLONAL ANTIBODIES
pp.:
415 – 431
CHAPTER 20 ANTIBODY-MEDIATED ARTHRITIS AND NEW THERAPEUTIC AVENUES
pp.:
431 – 451
CHAPTER 21 IMMUNONANOPARTICLES FOR NUCLEAR IMAGING AND RADIOTHERAPY
pp.:
451 – 481
CHAPTER 22 MONOCLONAL ANTIBODIES IN THE TREATMENT OF ASTHMA
pp.:
481 – 497